Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy bidirectional reshaping of the immunosuppressive microenvironment and controllable release of antigens

• Published in: Biomaterials science 2024-06, Vol.12 (12), p.3175-3192
• Main Authors: Qiu, Huimin, Wang, Shuman, Huang, Rimei, Liu, Xingyu, Li, Liqun, Liu, Zheng, Wang, Aihui, Ji, Shichen, Liang, Hong, Jiang, Bang-Ping, Shen, Xing-Can
• Format: Article
• ISSN: 2047-4830; 2047-4849
• DOI: 10.1039/d4bm00490f

The tumor immunosuppressive microenvironment (TIME) and uncontrollable release of antigens can lower the efficacy of nanovaccine-based immunotherapy (NBI). Therefore, it is necessary to develop a new strategy for TIME reshaping and controllable release of antigens to improve the NBI efficacy. Herein, an acidity-responsive Schiff base-conjugated polyphenol-coordinated nanovaccine was constructed for the first time to realize bidirectional TIME reshaping and controllable release of antigens for activating T cells. In particular, an acidity-responsive tannic acid-ovalbumin (TA-OVA) nanoconjugate was prepared via a Schiff base reaction. Fe III was coordinated with TA-OVA to produce a Fe III -TA-OVA nanosystem, and 1-methyltryptophan (1-MT) as an indoleamine 2,3-dioxygenase inhibitor was loaded to form a polyphenol-coordinated nanovaccine. The coordination between Fe III and TA could cause photothermal ablation of primary tumors, and the acidity-triggered Schiff base dissociation of TA-OVA could controllably release OVA to realize lysosome escape, initiating the body's immune response. More importantly, oxidative stress generated by a tumor-specific Fenton reaction of Fe ions could promote the polarization of tumor-associated macrophages from the M2 to M1 phenotype, resulting in the upregulation of cytotoxic T cells and helper T cells. Meanwhile, 1-MT could downregulate immunosuppressive regulatory T cells. Overall, such skillful combination of bidirectional TIME reshaping and controllable antigen release into one coordination nanosystem could effectively enhance the NBI efficacy of tumors. The tumor immunosuppressive microenvironment (TIME) and uncontrollable release of antigens can lower the efficacy of nanovaccine-based immunotherapy (NBI).